Workstream Type: Data Analysis

  • Cardiovascular Drugs Not Price Aligned with Value in US

  • Spending On Prescription Drugs In The US: Where Does All The Money Go?

    Spending On Prescription Drugs In The US: Where Does All The Money Go?

  • Impact of President Trump’s Proposed 340B Hospital Eligibility Threshold

    Impact of President Trump’s Proposed 340B Hospital Eligibility Threshold

  • Does the 6% in Medicare Part B Drug Reimbursement Affect Prescribing?

    Does the 6% in Medicare Part B Drug Reimbursement Affect Prescribing?

  • Association of Rebates in Part D with Patient OOP and Federal Spending

    Association of Rebates in Part D with Patient OOP and Federal Spending

  • R&D Costs Do Not Explain Elevated U.S. Drug Prices

  • Hospital Outpatient versus Doctor Office Cost for Physician Administered Cancer Drugs

    Hospital Outpatient versus Doctor Office Cost for Physician Administered Cancer Drugs

  • Part B Pilot Congressional Concerns

    Part B Pilot Congressional Concerns

  • Part B Payment for Medicare Drugs

    Part B Payment for Medicare Drugs

  • Overspending Driven by Oversized Single Dose Vials of Cancer Drugs

    Overspending Driven by Oversized Single Dose Vials of Cancer Drugs